Recce Pharmaceuticals (ASX:RCE) gains ethics approval to expand phase I/II trial of R327
Recce Pharmaceuticals (ASX:RCE) has obtained approval from the Human Research Ethics Committee to expand its trial…
| Wed, 26 Aug | Close | Change |
| 3:58pm | 9,134.5 | 30.1 |
| Closed at Thu, 27 Aug 2:00am | ||
| S&P/ASX Sm. Ords. | 3,584.0 | 4.70 | 0.13% |
| All Ordinaries | 9,345.4 | 29.5 | 0.31% |
| S&P/ASX 100 | 7,656.2 | 26.3 | 0.34% |